# Prophylactic Mirtazapine and Different Doses of Intrathecal Morphine in Preventing Nausea and Vomiting After Cesarean Section

> **NCT06681805** · NA · COMPLETED · sponsor: **Kafrelsheikh University** · enrollment: 120 (actual)

## Conditions studied

- Prophylactic
- Mirtazapine
- Intrathecal
- Morphine
- Nausea
- Vomiting

## Interventions

- **DRUG:** Mirtazapine + Bupivacaine + Morphine
- **DRUG:** Mirtazapine + Bupivacaine + Morphine
- **DRUG:** Placebo + Bupivacaine + Morphine
- **DRUG:** Placebo+ Bupivacaine + Morphine

## Key facts

- **NCT ID:** NCT06681805
- **Lead sponsor:** Kafrelsheikh University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-01-01
- **Primary completion:** 2024-09-25
- **Final completion:** 2024-09-25
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2024-11-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06681805

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06681805, "Prophylactic Mirtazapine and Different Doses of Intrathecal Morphine in Preventing Nausea and Vomiting After Cesarean Section". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06681805. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*